as a cancer-specific signaling network?
SignaLink contains interactions detected in healthy tissues. Merging cancer-specific expression patterns with SignaLink can reveal important changes in the signaling network, however, there can be signaling interactions present only in cancer cells and not in healthy ones. Therefore, SignaLink can be used only as a starting point for detailed analyses of cancer-specific signaling networks.
